3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
9
Squamous Cell Carcinoma of Head and Neck
4
Nasopharyngeal Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Esophageal Neoplasms
3
Pancreatic Neoplasms
2
Locally Advanced Rectal Cancer
2
Colonic Neoplasms
2
Cervical Cancer Metastatic
2
Breast Neoplasms
2
Adenocarcinoma
2
Turcot syndrome
1
Salivary Gland Neoplasms
1
Recurrence
1
Rectal Cancer Patients
1
Non-squamous Non-small-cell Lung Cancer
1
Mouth Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Gestational Trophoblastic Disease
1
Esophageal Squamour Cell Cancer
1
Endometrioid Endometrial Cancer
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Primary Liver Cancer
1
Interventions
Carboplatin
9
pembrolizumab
7
Pemetrexed
7
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiation
4
Nivolumab
4
Bevacizumab
4
Platinum
3
Paclitaxel
3
Mastectomy, Segmental
3
Cisplatin
3
Biopsy
3
fludarabine phosphate
2
durvalumab
2
capmatinib
2
aldesleukin
2
Taxes
2
Radiotherapy, Conformal
2
Radiosurgery
2
Ipilimumab
2
Interleukin-2
2
Immunoglobulin G
2
Disulfides
2
Cyclophosphamide
2
CTLA-4 Antigen
2
Anterior Temporal Lobectomy
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
camrelizumab
×
1 year
×
Clear all
No trials found.